REVANCE THERAPEUTICS INC's ticker is and the CUSIP is 761330AB5. A total of 20 filers reported holding REVANCE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,437,600 | -35.5% | 3,047,000 | -15.3% | 0.00% | – |
| Q2 2023 | $3,776,850 | -17.6% | 3,597,000 | -3.7% | 0.00% | – |
| Q1 2023 | $4,582,204 | +29.7% | 3,736,000 | -3.5% | 0.00% | – |
| Q4 2022 | $3,534,223 | -3.0% | 3,871,000 | +14.8% | 0.00% | – |
| Q3 2022 | $3,645,000 | -14.7% | 3,371,000 | -37.4% | 0.00% | -100.0% |
| Q2 2022 | $4,274,000 | +7.6% | 5,388,000 | +28.0% | 0.00% | 0.0% |
| Q1 2022 | $3,972,000 | +7.6% | 4,208,000 | 0.0% | 0.00% | – |
| Q4 2021 | $3,692,000 | -22.2% | 4,208,000 | +1.8% | 0.00% | -100.0% |
| Q3 2021 | $4,745,000 | -43.2% | 4,133,000 | -42.2% | 0.00% | 0.0% |
| Q2 2021 | $8,351,000 | -9.5% | 7,152,000 | -13.1% | 0.00% | 0.0% |
| Q1 2021 | $9,224,000 | – | 8,232,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Antara Capital LP | 49,500,000 | $47,535,000 | 1.45% |
| ZAZOVE ASSOCIATES LLC | 16,238,000 | $15,254,000 | 1.34% |
| Kohlberg Kravis Roberts & Co. L.P. | 26,000,000 | $24,456,000 | 0.22% |
| WEDBUSH SECURITIES INC | 30,000 | $2,807,000 | 0.13% |
| AVIVA PLC | 15,000,000 | $14,034,000 | 0.07% |
| Context Capital Management, LLC | 1,000 | $951,000 | 0.06% |
| LMR Partners LLP | 4,500,000 | $4,242,000 | 0.05% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 15,500,000 | $14,580,000 | 0.04% |
| LAZARD ASSET MANAGEMENT LLC | 27,770,000 | $26,121,000 | 0.03% |
| FRANKLIN RESOURCES INC | 48,000,000 | $45,150,000 | 0.02% |